WorldPharmaNews
Search ...
Home
Business
Research
Events
Regulatory
GSK is a global biopharma company with a purpose to unite science, technology, and talent to get ahead of disease together.
www.gsk.com
List of articles in category GlaxoSmithKline
Title
Published Date
GSK provides update on Herpevac trial for women evaluating Simplirix™
01 October 2010
GSK regulatory update on Avandia following EMA and FDA reviews
27 September 2010
GlaxoSmithKline and Genmab refocus development programme for ofatumumab in autoimmune indications
17 September 2010
GSK and BJD collaborate on a new educational programme to reduce global burden of joint pain
14 September 2010
BBC Panorama: "A Risk Worth Taking?" Programme. GlaxoSmithKline Right of Reply Statement
07 September 2010
Reports of narcolepsy in Europe following vaccination with Pandemrix™
06 September 2010
GSK commences Phase III clinical trials to develop herpes zoster vaccine for the prevention of shingles
24 August 2010
GlaxoSmithKline and Human Genome Sciences announce FDA priority review designation for Benlysta®
20 August 2010
Image of new antibiotic in action opens up new opportunities
09 August 2010
GlaxoSmithKline statement in response to FDA announcement on TIDE trial
22 July 2010
Start
Prev
10
11
12
13
14
15
16
17
18
19
Next
End
Business & Industry
Pfizer reports record full-year 2022 results
AMJEVITA™ (adalimumab-atto), first biosimilar to Humira® now available in the United States
CHMP recommends Bayer’s darolutamide for the treatment of metastatic hormone-sensitive prostate cancer
Roche announces the European Commission approval of Xofluza for the treatment and prevention of influenza in children aged one year and above
Pfizer expands 'An Accord for a Healthier World' product offering to include full portfolio for greater benefit to 1.2 billion people in 45 lower-income countries
Research & Development
Scientists pinpoint protein that helps cancer-causing viruses evade immune response
Transforming the way cancer vaccines are designed and made
Antidepressants used for chronic pain on the rise, but are they effective?
Keys to making immunotherapy work against pancreatic cancer found in tumor microenvironment
Discovery of anti-cancer chemistry makes skullcap fit for modern medicine
Coordination of COVID-19 vaccine clinical trials produces a 'treasure trove' of data and a model for the future
Power of cancer drugs may see boost by targeting newly ID'd pathway
Conferences & Events
SAE Media Group proudly presents the 4th Annual AI in Drug Discovery Conference
SAE Media Group's 6th annual 3D Cell Culture Conference
CPHI Frankfurt returns to pre-pandemic strength as pharma industry booms again
14th Annual RNA Therapeutics: Investigating the next generation of genetic medicine through RNA based therapies
CPHI Excellence in Pharma Award Winners 2022
CPHI Frankfurt Report predicts huge funding overhang to drive contract services growth
CPHI Frankfurt 2022: Global pharma confidence hits record high in the annual CPHI Pharma Index
Regulatory Affairs
FDA grants Accelerated Approval for Alzheimer's disease treatment
FDA approves new HIV drug for adults with limited treatment options
FDA approves first gene therapy for the treatment of high-risk, non-muscle-invasive bladder cancer
FDA approves first gene therapy to treat adults with Hemophilia B
FDA approves first treatment for Acid Sphingomyelinase Deficiency, a rare genetic disease
You are here:
Home
GlaxoSmithKline
First African country introduces GSK's pneumococcal vaccine